Biochemistry, Genetics and Molecular Biology
CREB
91%
Gene Expression
87%
Hepatic Stellate Cell
79%
Insulin Release
55%
Cyclic Adenosine Monophosphate
50%
CRTC2
48%
Peroxisome Proliferator-Activated Receptor
48%
Gluconeogenesis
44%
Glucagon
44%
Hepatocyte
43%
Transcription Factors
43%
Dynamics
43%
Lipid
41%
Beta Oxidation
40%
Agonist
39%
Lipid Metabolism
37%
Peroxisome Proliferator-Activated Receptor Alpha
35%
Transcription
31%
Glucose Homeostasis
29%
Dephosphorylation
25%
Insulin Resistance
25%
Metabolic Pathway
24%
Cell Membrane
23%
Myofibroblast
23%
Lipotoxicity
22%
Triglyceride
21%
Cell Activation
21%
RNA Sequence
20%
Transcriptomics
20%
AMP-activated Protein Kinase
20%
Programmed Cell Death
20%
Glucose Metabolism
19%
Peroxisome Proliferator-Activated Receptor Delta
17%
Cell Death
17%
RIPK3
17%
Functional Genomics
17%
Insulin Sensitivity
17%
Reprogramming
17%
Activating Transcription Factor 3
17%
ATF3
17%
Mitochondrial Respiration
17%
Hormone-Sensitive Lipase
17%
Epigenomics
17%
Necroptosis
17%
Histone Deacetylase
17%
CRTC1
17%
Binding Protein
17%
WD40 Repeat
17%
Epigenetics
17%
Carbohydrate Metabolism
17%
Medicine and Dentistry
Nonalcoholic Fatty Liver
90%
Hepatic Stellate Cell
79%
Fibrosis
57%
Liver Fibrosis
50%
Biological Marker
48%
Transcription Factors
31%
Cell Activation
26%
Fibrogenesis
24%
Steatohepatitis
22%
Pericyte
20%
Myofibroblast
20%
Hepatocyte
20%
Liver Injury
19%
Tamsulosin
19%
Stellate Cell
19%
Functional Genomics
17%
Hormone Sensitive Lipase
17%
Osteonectin
17%
Epigenomics
17%
Lipotoxicity
17%
Osteoprotegerin
17%
Disease Severity
17%
Calcium-Binding Protein
17%
Diagnostic Accuracy
17%
Beta Cell
17%
Metabolic Dysfunction-Associated Steatotic Liver Disease
17%
Proteome
17%
Melanoma
17%
Cancer Model
17%
Melanoma Skin Cancer
17%
Diseases
17%
Non-Alcoholic Fatty Liver Disease
16%
Liver Biopsy
12%
Transcriptomics
12%
Proteomics
11%
Triacylglycerol
11%
Gene Expression
11%
Liver Disease
9%
Elastography
8%
RNA Sequence
8%
Chronic Liver Disease
8%
Malignant Neoplasm
7%
Sinusoid
6%
Insulin Release
5%
Cell Membrane
5%
Transgenic Mouse
5%
Receptor
5%
High Fat Food
5%
Fatty Liver
5%
White Adipose Tissue
5%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Fatty Acid
95%
Fibrosis
60%
Peroxisome Proliferator Activated Receptor
45%
Biological Marker
41%
Liver Fibrosis
35%
Osteonectin
35%
Calcium Binding Protein
35%
Peroxisome Proliferator Activated Receptor Alpha
35%
Oleic Acid
33%
Transcription Factors
30%
Liver Disease
20%
Liver Injury
20%
Diseases
18%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
17%
Disease Severity
17%
Drug Screening
17%
Basonuclin
17%
Retinoid X Receptor Alpha
17%
Peroxisome Proliferator Activated Receptor Delta
17%
Melanoma Skin Cancer
17%
Cancer Model
17%
Melanoma
17%
Fatty Liver
16%
Retinoid X Receptor
14%
Unsaturated Fatty Acid
14%
Receptor Subtype
12%
Inflammation
11%
RNA-Sequencing
10%
Uncoupling Protein 2
10%
Chronic Liver Disease
9%
Receptor Agonist
8%
Malignant Neoplasm
7%
Carbon 14
7%
Long Term Exposure
6%
Triacylglycerol
5%
Phosphoprotein Phosphatase 2A
5%
Disease Exacerbation
5%
Lipotoxicity
5%
